Indicate Whether Each of the Following Descriptions Better Applies to Trastuzumab

Indicate whether each of the following descriptions better applies to trastuzumab (T) which targets Her2, imatinib (I) which targets Bcr-Abl, or ipilimumab (P) which targets the CTLA4 protein. Your answer would be a three-letter string composed of letters T, I, and P only, e.g. TTP.
( ) It is NOT an antibody.
( ) It counters the immunosuppressive microenvironment of tumors.
( ) It does not bind to a cancer cell component.

Correct Answer:

Verified

By binding to an inhibitory receptor o...

View Answer

Unlock this answer now
Get Access to more Verified Answers free of charge

View Full Answer For Free